Spark"s Play Pen Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Spark"s Play Pen

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Spark	4/1/2007 2:20:49 PM
	of 6175

Patients lining up for cancer 'magic bullet' canada.com Jodie Sinnema, The Edmonton Journal Published: Friday, March 16, 2007 Article tools Printer friendly EDMONTON - Desperate cancer patients are self-medicating with an inexpensive compound that has yet to be tested in humans, despite warnings of toxic poisonings and and even death from researchers at the University of Alberta, who used the chemical to shrink tumours in rats. Interest in dichloroacetate, or DCA, has skyrocketed since January, when the prominent academic journal Cancer Cell published a U of A doctor's findings that showed the compound -- used only in lab animals -- shrinks tumours without damaging healthy cells. People latched onto the news since DCA costs about $2 a dose and has been shown -- though only in ongoing clinical trials -- to be safe to treat people for metabolic disorders or heart disease. DCA is not available in pharmacies and has not been approved by Health Canada or the Food and Drug Administration in the United States.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next